Patents by Inventor Antonio Nicoletti

Antonio Nicoletti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230253792
    Abstract: A method for the reduction in the electricity consumption of an electrical load (2) placed along an electric line (3), said method comprising the steps of: —determining a phase shift existing between the current and voltage along the electric line (3); —implementing the following procedure if said phase shift falls within a predetermined range: i) performing an interruption of current to the electrical load (2) of a duration less than a predetermined value; ii) modifying an electrical characteristic of an additional electrical load (6) as a function of the phase shift; iii) putting or maintaining said additional electrical load (6) in parallel with the electrical load (2).
    Type: Application
    Filed: November 16, 2020
    Publication date: August 10, 2023
    Inventors: FILIPPO ANTONIO NICOLETTI, SALVATORE GIUSEPPE NICOLETTI, CALOGERO CALCAGNO
  • Publication number: 20040002111
    Abstract: The present invention relates to an antigenic composition capable of eliciting antibodies by interacting with &agr;&bgr; chains of a T cell receptor (TcR), which composition is comprised of a peptide-aldehyde conjugate. The aldehyde portion may be a dialdehyde, such as malondialdehyde (MDA), or a monoaldehyde, such as 4-hydroxynonenal (4-HNE), while the peptide portion preferably comprises at least one lysine residue. The antigenic composition according to the invention is capable of recognizing and interacting with a TcR having a complementarity-determining region 3 (CDR3) of &agr;10 and &bgr;6 chains that comprises a cluster of charged and polar amino acids. The invention also relates to a method of producing a vaccine against atherosclerosis by screening of a library of candidate compounds for their ability to bind to a conjugate of oxidized LDL and a dialdehyde as well as to such a vaccine as such.
    Type: Application
    Filed: December 19, 2002
    Publication date: January 1, 2004
    Inventors: Goran Hansson, Sten Stemme, Antonio Nicoletti, Dirk Wuttge